304 related articles for article (PubMed ID: 32119095)
1. Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries.
Rao T; Kiptanui Z; Dowell P; Triebwasser C; Alexander GC; Harris I
JAMA Netw Open; 2020 Mar; 3(3):e200274. PubMed ID: 32119095
[TBL] [Abstract][Full Text] [Related]
2. Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers.
Lin DH; Jones CM; Compton WM; Heyward J; Losby JL; Murimi IB; Baldwin GT; Ballreich JM; Thomas DA; Bicket M; Porter L; Tierce JC; Alexander GC
JAMA Netw Open; 2018 Jun; 1(2):e180235. PubMed ID: 30646077
[TBL] [Abstract][Full Text] [Related]
3. Opioid Prescribing Patterns and Complications in the Dermatology Medicare Population.
Cao S; Karmouta R; Li DG; Din RS; Mostaghimi A
JAMA Dermatol; 2018 Mar; 154(3):317-322. PubMed ID: 29417134
[TBL] [Abstract][Full Text] [Related]
4. Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population.
Bradford AC; Bradford WD; Abraham A; Bagwell Adams G
JAMA Intern Med; 2018 May; 178(5):667-672. PubMed ID: 29610897
[TBL] [Abstract][Full Text] [Related]
5. Prior Authorization for Opioid Use Disorder Versus Pain Medications: Lessons Learned for Parity Enforcement.
Mark TL; Parish WJ; Weber EM; Zarkin GA
J Stud Alcohol Drugs; 2021 Mar; 82(2):214-218. PubMed ID: 33823968
[TBL] [Abstract][Full Text] [Related]
6. Coverage of New Drugs in Medicare Part D.
Naci H; Kyriopoulos I; Feldman WB; Hwang TJ; Kesselheim AS; Chandra A
Milbank Q; 2022 Jun; 100(2):562-588. PubMed ID: 35502786
[TBL] [Abstract][Full Text] [Related]
7. Trends in Opioid Use and Prescribing in Medicare, 2006-2012.
Axeen S
Health Serv Res; 2018 Oct; 53(5):3309-3328. PubMed ID: 29532477
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016.
Gerlach LB; Kales HC; Kim HM; Zhang L; Strominger J; Covinsky K; Teno J; Bynum JPW; Maust DT
J Am Geriatr Soc; 2021 Jun; 69(6):1479-1489. PubMed ID: 33683703
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Nonopioid and Opioid Prescriptions Among Commercially Insured Patients with Chronic Pain.
Miller GF; Guy GP; Zhang K; Mikosz CA; Xu L
Pain Med; 2019 Oct; 20(10):1948-1954. PubMed ID: 30481359
[TBL] [Abstract][Full Text] [Related]
10. Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D.
Yarbrough CR
Health Serv Res; 2018 Apr; 53(2):671-689. PubMed ID: 28101955
[TBL] [Abstract][Full Text] [Related]
11. The association between the supply of select nonpharmacologic providers for pain and use of nonpharmacologic pain management services and initial opioid prescribing patterns for Medicare beneficiaries with persistent musculoskeletal pain.
Karmali RN; Skinner AC; Trogdon JG; Weinberger M; George SZ; Hassmiller Lich K
Health Serv Res; 2021 Apr; 56(2):275-288. PubMed ID: 33006158
[TBL] [Abstract][Full Text] [Related]
12. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
[TBL] [Abstract][Full Text] [Related]
13. Emergency Providers' Opioid Prescribing Behaviors Among Medicare Part D Beneficiaries in North Carolina, 2013-2014: Medication Utilization and Costs.
Williams B; Mospan G; Seabock R; Gillette C; DeGeeter M
N C Med J; 2018; 79(3):143-148. PubMed ID: 29735614
[No Abstract] [Full Text] [Related]
14. Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries.
Mark TL; Parish WJ; Zarkin GA
JAMA Netw Open; 2020 Apr; 3(4):e203132. PubMed ID: 32310285
[TBL] [Abstract][Full Text] [Related]
15. Opioid use in older adults and Medicare Part D.
Sabety AH; Sherry TB; Maestas N
Health Serv Res; 2021 Apr; 56(2):289-298. PubMed ID: 33462819
[TBL] [Abstract][Full Text] [Related]
16. Medicare Part D Coverage Restrictions and Patient Cost-Sharing for Opioids Commonly Used for Cancer Pain, 2015-2021.
Bao Y; Zhang H; Hartung DM; Witkin LR; Paice JA
JCO Oncol Pract; 2022 Oct; 18(10):e1574-e1586. PubMed ID: 35797497
[TBL] [Abstract][Full Text] [Related]
17. Medicare Advantage coverage restrictions for the costliest physician-administered drugs.
Anderson KE; Alexander GC; Ma C; Dy SM; Sen AP
Am J Manag Care; 2022 Jul; 28(7):e255-e262. PubMed ID: 35852888
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Long-Term Prescription Opioid Use Among Older Adults in the United States: A Study of Medicare Administrative Claims Data.
Ramachandran S; Salkar M; Bentley JP; Eriator I; Yang Y
Pain Physician; 2021 Jan; 24(1):31-40. PubMed ID: 33400426
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Coverage Restrictions on Antipsychotic Utilization Among Low-Income Medicare Part D Enrollees.
Roberto PN; Brandt N; Onukwugha E; Perfetto E; Powers C; Stuart B
Adm Policy Ment Health; 2017 Nov; 44(6):943-954. PubMed ID: 28660370
[TBL] [Abstract][Full Text] [Related]
20. Changes in Opioid Prescribing Patterns Among Generalists and Oncologists for Medicare Part D Beneficiaries From 2013 to 2017.
Agarwal A; Roberts A; Dusetzina SB; Royce TJ
JAMA Oncol; 2020 Aug; 6(8):1271-1274. PubMed ID: 32469405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
